Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older [Phase 1]
Phase 1 trial evaluating safety and immune response of an investigational mRNA vaccine designed to prevent Respiratory Syncytial Virus infec…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years [Phase 1]
Phase 1 study assessing the safety and immunogenicity of an mRNA-based RSV investigational vaccine in healthy adults aged 18-45. The trial i…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
This clinical trial update reports on the effectiveness of Nirsevimab in children hospitalized with RSV bronchiolitis.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age [Phase 1]
Phase 1 study evaluating infectivity, safety, and immunogenicity of a recombinant live-attenuated RSV vaccine (LID/ΔM2-2/1030s) in RSV-seron…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older [Phase 1]
Phase 1 clinical trial evaluating safety and immunogenicity of a recombinant Respiratory Syncytial Virus vaccine in adults 18 years and olde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age [Phase 2, Phase 3]
This clinical trial evaluated the safety and efficacy of Moderna's RSV vaccine mRNA-1345 in adults aged 60 and older, spanning Phase 2 and P…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety of inhaled XW001 in children with Respiratory syncytial virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease [Phase 3]
Phase 3 study evaluating Pfizer's RSVpreF vaccine for safety, tolerability, and immunogenicity in adults at high risk of severe RSV disease …
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Pfizer completed a Phase 2 trial evaluating multiple doses of sisunatovir in individuals with respiratory syncytial virus infection. The upd…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults [Phase 1]
Phase 1 study evaluating the effect of Zelicapavir (EDP-938) on the QTc interval in healthy adults, with RSV infection listed as a condition…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection [Phase 2]
A Phase 2 study evaluating Obeldesivir for treating RSV infection in nonhospitalized adults was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV [Phase 2]
A Phase 2 clinical trial evaluating Deuremidevir Hydrobromide for Suspension in Chinese infants hospitalized with Respiratory Syncytial Viru…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above [Phase 2]
Phase 2 study evaluating immune response and safety of an RSV vaccine in adults 18 and older who received lung or kidney transplants and are…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants [Phase 3]
A Phase 3 clinical trial evaluating the RSVpreF vaccine in pregnant participants with HIV and their infants has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus [Phase 2]
Phase 2 clinical trial of Moderna's RSV vaccine mRNA-1345 in children aged 2 to under 18 at high risk has been completed.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Study to Evaluate EDP 938 Regimens in Children With RSV [Phase 2]
A Phase 2 study evaluating regimens of the RSV antiviral EDP-938 in children has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Assessing Antiviral Treatments in Early Symptomatic RSV [Phase 2]
Phase 2 clinical trial led by the University of Oxford is evaluating antiviral treatments for early symptomatic respiratory syncytial virus …
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. [Phase 1]
This Phase 1 drug-drug interaction study evaluated how itraconazole, carbamazepine, quinidine, and fluconazole affect the pharmacokinetics a…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
This clinical trial update reports the completion of a study evaluating Labcorp's home collection kit for simultaneous testing of COVID-19, …
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
A Phase 2 study evaluating Obeldesivir for treating RSV infection in children was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of a recombinant RSV vaccine produced in CHO cells in healthy adults aged …
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults [Phase 1]
A first-in-human Phase 1 study evaluating the safety and immunogenicity of RSV vaccine candidates SCB-1019 and SCB-1019T in healthy adults h…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports the completion of safety and immunogenicity testing for an RSV vaccine candidate delivered in a li…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection
This clinical trial update reports on the duration of protection provided by nirsevimab against hospitalization due to respiratory syncytial…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants [Phase 3]
Phase 3 study of the Ad26.RSV.preF-based vaccine for prevention of RSV-mediated lower respiratory tract disease in Japanese participants has…